Carle Cancer Center Community Clinical Oncology Program

描述(申请人提供)：为了响应RFA CA-03-011社区临床肿瘤学计划，国家癌症研究所、伊利诺伊州厄巴纳的卡尔癌症中心正在申请继续被指定为伊利诺伊州中东部的CCOP。作为伊利诺伊州第二大私人医疗团体，Carle Clinic Association拥有近300名医生，拥有完善的社区癌症中心项目，自1976年以来一直参与国家临床试验研究。卡勒癌症中心自1983年项目开始以来，一直作为CCOP得到资助。与Carle一起参与CCOP申请的机构还有伊利诺伊州Joliet的Joliet肿瘤学血液协会、伊利诺伊州奥罗拉的Rush-Copley癌症中心和墨西哥墨西哥城的墨西哥国家癌症研究所。合并后的Carle癌症中心CCOP为来自伊利诺伊州中东部和印第安纳州西部38个县、芝加哥、伊利诺伊州南部和西南部以及墨西哥墨西哥城4个县的癌症患者提供服务。CCOP的总部设在卡勒癌症中心，在伊利诺伊州的厄巴纳管理着所有的随机化、行政事务和质量保证计划。CCOPS的主要研究基地是北中癌症治疗小组。还与东部合作肿瘤学小组和国家外科辅助乳肠项目有很强的联系。2001年开始与MD安德森癌症中心建立新的合作关系。这个 Carle癌症中心及其附属公司有专门的临床研究助理、护士和行政人员，协助30名调查内科和放射肿瘤学家将患者和参与者安排在临床研究试验中，每年应产生约135个治疗积分和210个癌症控制积分。Carle癌症中心CCOP的目标是为自己社区内的个人提供先进的癌症护理和预防。为此，获得和参与NCI癌症预防、检测和治疗的临床试验提供了最高标准的护理和对未来最光明的希望。

DESCRIPTION (provided by applicant): In response to RFA CA-03-011 Community Clinical Oncology Program, National Cancer institute, the Carle Cancer Center, Urbana, Illinois is making an application to continue to be designated as a CCOP in East Central Illinois. As the second largest private medical group practice in Illinois, with nearly 300 physicians, the Carle Clinic Association has a fully developed community cancer center program, which has been involved in national clinical trials research since 1976. The Carle Cancer Center has been continuously funded as a CCOP since the program's inception in 1983. Joining Carle in this CCOP application as component institutions are the Joliet Oncology Hematology Associates in Joliet, Illinois, Rush-Copley Cancer Center in Aurora, Illinois, and the National Cancer Institute of Mexico in Mexico City, Mexico. The combined Carle Cancer Center CCOP provides services to cancer patients from a large catchment area of 38 counties in east central Illinois and western Indiana, 4 counties south and southwest of Chicago, Illinois and in Mexico City, Mexico. The headquarters for the CCOP is located at the Carle Cancer Center with all randomizations, administrative matters and quality assurance programs managed in Urbana, Illinois. The CCOPs primary research base is the North Central Cancer Treatment Group. There are also strong affiliations with the Eastern Cooperative Oncology Group and the National Surgical Adjuvant Breast and Bowel Project. A new affiliation with the MD Anderson Cancer Center was begun in 2001. The Carle Cancer Center and it's affiliates have dedicated clinical research associates, nurses, and administrative staff to assist 30 investigating medical and radiation oncologists in placing patients and participants on clinical research trials that should result in approximately 135 treatment credits and 210 cancer control credits annually. The goal of the Carle Cancer Center CCOP is to provide progressive state of the art cancer care and prevention to individuals within their own communities. To this end, access and participation in NCI clinical trials of cancer prevention, detection and treatment offer the highest standard of care and the brightest hope for the future.